The apparent inactivity of the hemostatic system under normal circumstances and its rapid mobilization during episodes of hemostatic stress indicates that it is tightly regulated. The objective of this Program Project is to study this regulation. Because hemostasis invovles an interplay between endothelial cells and circulating platelets, the Program Project will focus on the regulation of platelet and endothelial cell function. The Program Project consists of seven projects and three core units. Project 1 will use molecular genetic, biochemical, and ultrastructural techniques to define functional domains in the platelet membrane llb/llla heterodimer complex which contains the platelet fibrinogen receptor required for platelet aggregation. Project 2 will focus on the molecular biology of llb/llla, examining the organization of the genes for these proteins and determining the genetic mechanisms responsible for Glanzmann's thrombasthenia. Project 3 will investigate factors involved in the exposure of the fibrinogen receptor on activated platelets with emphasis on the specific role of guanine-nucleotide binding proteins. The nature of the fibrinogen binding site on llb/llla will be examined, as will clinical abnormalities of platelet activation abnormalities. Project 4 will study stimulus-response coupling in platelets through an examination of the role of guanine-nucleotide binding proteins, phosphoinositides, and calcium in this process. Project 5 will examine the molecular mechanisms of icosanoid production. These compounds are mediators of cellular activation in platelets and endothelial cells. Project 6 will examine the role of immune injury of vascular lining cells in abnormal regulation of hemostatsis. The effect of lupus inhibitors on endothelial cell and trophoblast function and the interaction of plasminogen activators and inhibitors with these cells will be studied. Project 7 will study of the structure and function of the platelet Fc(gamma) receptor to understand the mechanisms by which immune complexes activate platelets and shorten platelet survival. To support these projects, core units for cell culture and monoclonal antibody production, for molecular biology technology, and for administration will be established. Abnormalities in the regulation of hemostasis play an important role in the pathogenesis of processes such atherosclerotic vascular disease and arterial and venous thrombosis. Understanding these abnormalities may provide rational methods for the treatment of these dieases.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL040387-05
Application #
3098660
Study Section
Heart, Lung, and Blood Research Review Committee B (HLBB)
Project Start
1988-04-01
Project End
1993-06-30
Budget Start
1992-04-01
Budget End
1993-06-30
Support Year
5
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Capitano, Maegan; Zhao, Liang; Cooper, Scott et al. (2018) Phosphatidylinositol transfer proteins regulate megakaryocyte TGF-?1 secretion and hematopoiesis in mice. Blood 132:1027-1038
Branchford, B R; Stalker, T J; Law, L et al. (2018) The small-molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis. J Thromb Haemost 16:352-363
Zhao, Baobing; Mei, Yang; Cao, Lan et al. (2018) Loss of pleckstrin-2 reverts lethality and vascular occlusions in JAK2V617F-positive myeloproliferative neoplasms. J Clin Invest 128:125-140
Khandelwal, Sanjay; Ravi, Joann; Rauova, Lubica et al. (2018) Polyreactive IgM initiates complement activation by PF4/heparin complexes through the classical pathway. Blood 132:2431-2440
Villa, Carlos H; Pan, Daniel C; Johnston, Ian H et al. (2018) Biocompatible coupling of therapeutic fusion proteins to human erythrocytes. Blood Adv 2:165-176
Ma, Peisong; Gupta, Shuchi; Sampietro, Sara et al. (2018) RGS10 shapes the hemostatic response to injury through its differential effects on intracellular signaling by platelet agonists. Blood Adv 2:2145-2155
Gupta, Shuchi; Cherpokova, Deya; Spindler, Markus et al. (2018) GPVI signaling is compromised in newly formed platelets after acute thrombocytopenia in mice. Blood 131:1106-1110
Xie, Zhigang; Hur, Seong Kwon; Zhao, Liang et al. (2018) A Golgi Lipid Signaling Pathway Controls Apical Golgi Distribution and Cell Polarity during Neurogenesis. Dev Cell 44:725-740.e4
Greineder, Colin F; Johnston, Ian H; Villa, Carlos H et al. (2017) ICAM-1-targeted thrombomodulin mitigates tissue factor-driven inflammatory thrombosis in a human endothelialized microfluidic model. Blood Adv 1:1452-1465
Welsh, J D; Poventud-Fuentes, I; Sampietro, S et al. (2017) Hierarchical organization of the hemostatic response to penetrating injuries in the mouse macrovasculature. J Thromb Haemost 15:526-537

Showing the most recent 10 out of 290 publications